サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1562394

欧州のサルコペニア治療：2030年までの市場予測 - 地域分析 - 治療タイプ別、流通チャネル別

Europe Sarcopenia Treatment Market Forecast to 2030 - Regional Analysis - by Treatment Type and Distribution Channel

出版日
ページ情報
英文 78 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
欧州のサルコペニア治療：2030年までの市場予測 - 地域分析 - 治療タイプ別、流通チャネル別
出版日: 2024年07月04日
発行: The Insight Partners
ページ情報: 英文 78 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州のサルコペニア治療市場は、2022年に9億9,346万米ドルと評価され、2030年には14億6,781万米ドルに達すると予測され、2022年から2030年までのCAGRは5.0%と推定されます。

成人における栄養不良とビタミン欠乏の増加が欧州のサルコペニア治療市場を押し上げる

栄養不良はサルコペニアの主要な危険因子の一つです。WHOによると、2021年時点で世界の成人約23億人が栄養不足に陥っており、これは世界人口の約30%に相当します。報告されている危険因子のうち、タンパク質・エネルギー不足はサルコペニアの原因として頻度が高いです。さらに、ビタミンDの欠乏または不足は、がん、肥満、心血管疾患、サルコペニアなどの複数の病気のリスク上昇と正の相関があります。米国国立衛生研究所（NIH）によると、世界人口の50％近くがビタミンD不足に苦しんでおり、10億人がビタミンD欠乏症です。

欧州のサルコペニア治療市場概要

欧州のサルコペニア治療市場は、ドイツ、フランス、英国、イタリア、スペイン、その他欧州に区分されます。欧州は世界のサルコペニア治療市場において重要な位置を占めており、市場推計・予測期間中に顕著なCAGRを記録すると推定されます。

ドイツは、ヘルスケアに対する革新的なアプローチにより魅力的な市場です。連邦統計局によると、同国の医療費は2021年に4,740億米ドルに達しました。サルコペニアとサルコペニア性肥満（SO）に対する認識は、ドイツ全土の高齢化社会で徐々に高まっています。ドイツの70歳以上の男性では、サルコペニアとSOは比較的まれ（5％未満）です。そのため、整形外科疾患のケースの急増と栄養補助食品に対する需要の高まりが、ドイツのサルコペニア治療市場の成長を牽引しています。

欧州のサルコペニア治療市場の収益と2030年までの予測（金額）

欧州のサルコペニア治療市場のセグメンテーション

欧州のサルコペニア治療市場は、治療タイプ、流通チャネル、国別に分類されます。

治療タイプに基づき、欧州のサルコペニア治療市場はビタミンD・カルシウムサプリメント、タンパク質サプリメント、ビタミンB12サプリメント、その他に区分されます。2022年の欧州のサルコペニア治療市場シェアは、ビタミンD・カルシウムサプリメントセグメントが最大でした。

流通チャネルでは、欧州のサルコペニア治療市場は薬局、小売チャネル、オンラインチャネル、その他に区分されます。2022年の欧州のサルコペニア治療市場シェアは薬局セグメントが最大でした。

国別では、欧州のサルコペニア治療市場はドイツ、フランス、イタリア、英国、スペイン、その他欧州に区分されます。2022年の欧州のサルコペニア治療市場シェアはドイツが独占。

Abbott Laboratories社、Amway Corp社、Bayer AG社、GSK Plc社、Metagenics LLC社、Nestle Health Science SA社、Novartis AG社、Pfizer Inc社、Sanofi SA社は、欧州のサルコペニア治療市場で事業を展開する主要企業の一部です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 欧州のサルコペニア治療市場：主要産業力学

  • 欧州のサルコペニア治療市場：主要産業力学
  • 市場促進要因
    • 高齢者の増加
    • 成人における栄養不良とビタミン欠乏症の増加
  • 主な市場抑制要因
    • 直接的な治療法の入手不可能性
  • 主な市場機会
    • 臨床試験段階の製品
  • 今後の動向
    • サルコペニアに対する意識の高まり
  • 促進要因と抑制要因の影響

第5章 サルコペニア治療市場：欧州市場分析

  • 欧州のサルコペニア治療市場収益、2020年～2030年
  • 欧州のサルコペニア治療市場の予測と分析

第6章 欧州のサルコペニア治療市場分析：治療タイプ別

  • ビタミンDおよびカルシウムサプリメント
  • タンパク質サプリメント
  • ビタミンB12サプリメント
  • その他

第7章 欧州のサルコペニア治療市場分析：流通チャネル別

  • 薬局
  • 小売チャネル
  • オンラインチャネル
  • その他

第8章 欧州のサルコペニア治療市場：国別分析

  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他欧州

第9章 サルコペニア治療市場：業界情勢

  • サルコペニア治療市場における成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第10章 企業プロファイル

  • Abbott Laboratories
  • Bayer AG
  • Metagenics LLC
  • Nestle Health Science SA
  • Novartis AG
  • Pfizer Inc
  • Sanofi SA
  • Amway Corp
  • GSK Plc

第11章 付録

図表

List Of Tables

  • Table 1. Europe Sarcopenia Treatment Market Segmentation
  • Table 2. Sarcopenia Drug Under Clinical Development
  • Table 3. Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million)
  • Table 4. Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Treatment Type
  • Table 5. Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Distribution Channel
  • Table 6. Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Country
  • Table 7. Germany Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 8. Germany Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 9. France Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 10. France Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 11. United Kingdom Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 12. United Kingdom Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 13. Italy Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 14. Italy Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 15. Spain Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 16. Spain Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 17. Rest of Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 18. Rest of Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 19. Recent Inorganic Growth Strategies in the Sarcopenia Treatment Market
  • Table 20. Recent Organic Growth Strategies in the Sarcopenia Treatment Market
  • Table 21. Glossary of Terms, Sarcopenia Treatment Market

List Of Figures

  • Figure 1. Europe Sarcopenia Treatment Market Segmentation, By Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. Europe Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
  • Figure 4. Europe Sarcopenia Treatment Market Share (%) - By Treatment Type, 2022 and 2030
  • Figure 5. Vitamin D and Calcium Supplement: Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 6. Protein Supplement: Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 7. Vitamin B12 Supplement: Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 8. Others: Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 9. Europe Sarcopenia Treatment Market Share (%) - By Distribution Channel, 2022 and 2030
  • Figure 10. Pharmacies : Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 11. Retail Channels : Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 12. Online Channels : Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 13. Others : Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 14. Europe Sarcopenia Treatment Market Revenue, by Key Countries, (2022) (US$ Mn)
  • Figure 15. Europe Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)
  • Figure 16. Germany Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 17. France Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 18. United Kingdom Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 19. Italy Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 20. Spain Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 21. Rest of Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 22. Growth Strategies in the Sarcopenia Treatment Market
目次
Product Code: BMIRE00030430

The Europe sarcopenia treatment market was valued at US$ 993.46 million in 2022 and is expected to reach US$ 1,467.81 million by 2030; it is estimated to register a CAGR of 5.0% from 2022 to 2030.

Rise in Malnutrition and Vitamin Deficiency Among Adults Boosts Europe Sarcopenia Treatment Market

Malnutrition is one of the major risk factors for sarcopenia. According to the WHO, approximately 2.3 billion adults worldwide were undernourished as of 2021, representing nearly 30% of the global population. Among the reported risk factors, protein-energy deficiency is a frequent cause of sarcopenia. Further, vitamin D deficiency or insufficiency is positively associated with an increased risk of multiple illnesses, such as cancer, obesity, cardiovascular disease, and sarcopenia. According to the National Institutes of Health (NIH), nearly 50% of the world's population suffers from vitamin D insufficiency, and ~1 billion people are vitamin D deficient.

Europe Sarcopenia Treatment Market Overview

The sarcopenia treatment market in Europe is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Europe occupies a significant position in the global sarcopenia treatment market and is estimated to register a notable CAGR during the forecast period.

Germany is an attractive market due to its innovative approach toward healthcare. According to the Federal Statistical Office, health expenditure in this country amounted to US$ 474 billion in 2021. The awareness of sarcopenia and sarcopenic obesity (SO) is gradually increasing in aging societies across Germany. Sarcopenia and SO are comparatively uncommon (<5%) among German men aged 70 and above. Therefore, an upsurge in the cases of orthopedic disorders, coupled with the rising demand for nutritional supplements, drives the growth of the sarcopenia treatment market in Germany.

Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)

Europe Sarcopenia Treatment Market Segmentation

The Europe sarcopenia treatment market is categorized into treatment type, distribution channel, and country.

Based on treatment type, the Europe sarcopenia treatment market is segmented into vitamin D and calcium supplement, protein supplement, vitamin B12 supplement, and others. The vitamin D and calcium supplement segment held the largest Europe sarcopenia treatment market share in 2022.

In terms of distribution channel, the Europe sarcopenia treatment market is segmented into pharmacies, retail channels, online channels, and others. The pharmacies segment held the largest Europe sarcopenia treatment market share in 2022.

By country, the Europe sarcopenia treatment market is segmented into Germany, France, Italy, the UK, Spain, and the Rest of Europe. Germany dominated the Europe sarcopenia treatment market share in 2022.

Abbott Laboratories, Amway Corp, Bayer AG, GSK Plc, Metagenics LLC, Nestle Health Science SA, Novartis AG, Pfizer Inc, and Sanofi SA are some of the leading companies operating in the Europe sarcopenia treatment market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Sarcopenia Treatment Market - Key Industry Dynamics

  • 4.1 Europe Sarcopenia Treatment Market - Key Industry Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Upsurge in Geriatric Population
    • 4.2.2 Rise in Malnutrition and Vitamin Deficiency Among Adults
  • 4.3 Key Market Restraints:
    • 4.3.1 Unavailability of Direct Interventions
  • 4.4 Key Market Opportunities:
    • 4.4.1 Products in Clinical Trial Phases
  • 4.5 Future Trends:
    • 4.5.1 Rising Awareness About Sarcopenia
  • 4.6 Impact of Drivers and Restraints:

5. Sarcopenia Treatment Market - Europe Market Analysis

  • 5.1 Europe Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
  • 5.2 Europe Sarcopenia Treatment Market Forecast and Analysis

6. Europe Sarcopenia Treatment Market Analysis - By Treatment Type

  • 6.1 Vitamin D and Calcium Supplement
    • 6.1.1 Overview
    • 6.1.2 Vitamin D and Calcium Supplement: Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.2 Protein Supplement
    • 6.2.1 Overview
    • 6.2.2 Protein Supplement: Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.3 Vitamin B12 Supplement
    • 6.3.1 Overview
    • 6.3.2 Vitamin B12 Supplement: Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Others
    • 6.4.1 Overview
    • 6.4.2 Others: Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)

7. Europe Sarcopenia Treatment Market Analysis - By Distribution Channel

  • 7.1 Pharmacies
    • 7.1.1 Overview
    • 7.1.2 Pharmacies : Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Retail Channels
    • 7.2.1 Overview
    • 7.2.2 Retail Channels : Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Online Channels
    • 7.3.1 Overview
    • 7.3.2 Online Channels : Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Others
    • 7.4.1 Overview
    • 7.4.2 Others : Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)

8. Europe Sarcopenia Treatment Market - Country Analysis

  • 8.1 Europe
    • 8.1.1 Europe Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
      • 8.1.1.1 Europe Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
      • 8.1.1.2 Germany Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 8.1.1.2.1 Germany Sarcopenia Treatment Market Breakdown by Treatment Type
        • 8.1.1.2.2 Germany Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 8.1.1.3 France Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 8.1.1.3.1 France Sarcopenia Treatment Market Breakdown by Treatment Type
        • 8.1.1.3.2 France Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 8.1.1.4 United Kingdom Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 8.1.1.4.1 United Kingdom Sarcopenia Treatment Market Breakdown by Treatment Type
        • 8.1.1.4.2 United Kingdom Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 8.1.1.5 Italy Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 8.1.1.5.1 Italy Sarcopenia Treatment Market Breakdown by Treatment Type
        • 8.1.1.5.2 Italy Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 8.1.1.6 Spain Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 8.1.1.6.1 Spain Sarcopenia Treatment Market Breakdown by Treatment Type
        • 8.1.1.6.2 Spain Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 8.1.1.7 Rest of Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 8.1.1.7.1 Rest of Europe Sarcopenia Treatment Market Breakdown by Treatment Type
        • 8.1.1.7.2 Rest of Europe Sarcopenia Treatment Market Breakdown by Distribution Channel

9. Sarcopenia Treatment Market-Industry Landscape

  • 9.1 Overview
  • 9.2 Growth Strategies in the Sarcopenia Treatment Market
  • 9.3 Inorganic Growth Strategies
    • 9.3.1 Overview
  • 9.4 Organic Growth Strategies
    • 9.4.1 Overview

10. Company Profiles

  • 10.1 Abbott Laboratories
    • 10.1.1 Key Facts
    • 10.1.2 Business Description
    • 10.1.3 Products and Services
    • 10.1.4 Financial Overview
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Developments
  • 10.2 Bayer AG
    • 10.2.1 Key Facts
    • 10.2.2 Business Description
    • 10.2.3 Products and Services
    • 10.2.4 Financial Overview
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Developments
  • 10.3 Metagenics LLC
    • 10.3.1 Key Facts
    • 10.3.2 Business Description
    • 10.3.3 Products and Services
    • 10.3.4 Financial Overview
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Developments
  • 10.4 Nestle Health Science SA
    • 10.4.1 Key Facts
    • 10.4.2 Business Description
    • 10.4.3 Products and Services
    • 10.4.4 Financial Overview
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Developments
  • 10.5 Novartis AG
    • 10.5.1 Key Facts
    • 10.5.2 Business Description
    • 10.5.3 Products and Services
    • 10.5.4 Financial Overview
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Developments
  • 10.6 Pfizer Inc
    • 10.6.1 Key Facts
    • 10.6.2 Business Description
    • 10.6.3 Products and Services
    • 10.6.4 Financial Overview
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Developments
  • 10.7 Sanofi SA
    • 10.7.1 Key Facts
    • 10.7.2 Business Description
    • 10.7.3 Products and Services
    • 10.7.4 Financial Overview
    • 10.7.5 SWOT Analysis
    • 10.7.6 Key Developments
  • 10.8 Amway Corp
    • 10.8.1 Key Facts
    • 10.8.2 Business Description
    • 10.8.3 Products and Services
    • 10.8.4 Financial Overview
    • 10.8.5 SWOT Analysis
    • 10.8.6 Key Developments
  • 10.9 GSK Plc
    • 10.9.1 Key Facts
    • 10.9.2 Business Description
    • 10.9.3 Products and Services
    • 10.9.4 Financial Overview
    • 10.9.5 SWOT Analysis
    • 10.9.6 Key Developments

11. Appendix

  • 11.1 About The Insight Partners
  • 11.2 Glossary of Terms